VentriPoint Diagnostics Ltd.
VPTDF
$0.08
$0.00-3.22%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 36.29% | 22.50% | 11.60% | 3.34% | 0.44% |
| Total Depreciation and Amortization | -4.58% | -7.22% | -8.54% | -9.20% | -6.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.94% | -0.97% | 211.26% | 118.53% | 39.13% |
| Change in Net Operating Assets | 52.78% | 176.18% | 44.77% | 83.10% | 51.87% |
| Cash from Operations | 55.02% | 55.44% | 43.71% | 27.10% | 12.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -21.49% | -27.61% | 18.76% | -- | -- |
| Total Debt Repaid | 23.10% | 23.67% | 22.92% | 24.81% | -53.91% |
| Issuance of Common Stock | -44.61% | 212.17% | 3,113.30% | 2,199.47% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 22.11% | -91.91% | -256.40% | -- | -- |
| Cash from Financing | -31.84% | 9.46% | 128.71% | 2,393.93% | 2,204.22% |
| Foreign Exchange rate Adjustments | 135.76% | -2,133.33% | 114.52% | -- | -415.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.69% | 97.63% | 97.74% | 99.10% | 68.40% |